Sport Racing

The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.

By: Business Insider

Dec 26 2024
7
324 Views

The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.

Tirzepatide, a once-weekly injection to treat diabetes and obesity, is no longer in shortage, the FDA announced, potentially signaling a crackdown on copycat drugs in early 2025.MarsBars/Getty Images… [+4859 chars]

Cherry Los Angeles Taps VERDY for Three-Piece Girls Don't Cry Capsule

The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.

Here are 20+ last-minute Apple gift ideas with fast shipping

Baidu confirmed as China Apple Intelligence model provider, but privacy concerns mount

Bayer's CEO said budgets represent the worst of corporate bureaucracy. He decided to turn the process on its head.

NYT Crossword: answers for Monday, December 23

What's ahead for AI in 2025, according to a Google executive

New Free-To-Play Gran Turismo Game Revealed, And It's Out Very Soon

Watch: Jetson founder tests the air for future eVTOL racing

US Senate approves Social Security change despite fiscal concerns

Here are 20+ last-minute Apple gift ideas with holiday delivery

Building A Custom Swiss Army Knife

Facebook

Pinterest

Linkedin

Jan Jansen Easy Branches

Tumblr

Easy Branches

Instagram

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.

Related